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The natural history of Vestibular Schwannomas (VS) is 
yet not totally known, but most of them have the tendency 
to slow growth, sometimes without any kind of symptoms 
during the individual’s entire time. About 69% of diagnosed 
VS do not grow at all and 16% of these can even regress. 
Considering tumors that grow, about 70% have grown 
less than 2mm an year. Advanced radiological diagnosis, 
especially magnetic resonance imaging with gadolinium helps 
us diagnose small and less symptomatic tumors. Treatment of 
choice still is complete tumor resection. Surgical approaches 
have improved considerably and have helped preserve facial 
nerve function and hearing. Considering VS’s natural history, 
there is a possibility for conservative treatment for these 
tumors, because their growth in the first year after diagnosis 
predicts tumor growth behavior in the next years. Surgery 
should be done in cases of tumor growth, patient’s desire or 
symptoms worsening. Moreover, in terms of postoperative 
sequelae, there is no difference between patients who 
underwent surgery immediately after diagnosis and those who 
underwent initial conservative treatment for these tumors.
Keywords: acoustic neuromas, vestibular schwannoma, 
treatment.
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INTRODUCTION
The last decades have seen substantial changes in 
how vestibular schwannomas (VS) are approached, thanks 
to further knowledge acquired in regards of their natural 
history associated with an improvement in diagnostic 
methods and treatment techniques
Most of the times, VS is a benign slow growing 
tumor, and it may remain asymptomatic throughout the 
patient’s life, diagnosed only during autopsies 1.
The major development in image exams, especially 
gadolinium-contrasted MRI, led to an increase in the 
number of VS diagnosed, especially the small ones with 
minimal symptoms, which were missed in the past. 
Moreover, there was a major development in VS 
treatment, with improvements in surgical approaches 
together with the use of the surgical microscope, and the 
pioneer in it was Dr. William House in 1961, which caused 
a marked reduction in the mortality associated with this 
surgical procedure, down to levels below 1%. With that, 
surgery for VS, which was described in the beginning of 
the previous century, but carefully considered because it 
bears high morbi-mortality rates2, became the treatment 
of choice for most patients. 
Due to the progress in microsurgical techniques, 
the goal of surgery is no longer complete tumor removal, 
but also hearing and facial nerve preservation. However, 
these goals are not always achieved after surgical proce-
dure, and it may cause hearing loss and some degree of 
facial paresis.
Based on these data, we see the need for a conser-
vative approach in selected patients with VS. We hereby 
report on two cases in which there has been tumor re-
gression during the observation period.
CLINICAL CASES
 
Case 1
OV, 48 years, male, white.
Came to us complaining of tinnitus and hearing loss 
in his right ear for one year. He had normal physical exam. 
His audiogram showed a sensorineural hearing loss in the 
high frequencies of his right ear (Figure 1a). MRI showed 
a mass in his right inner acoustic meatus, measuring 1.0 
x 0.6 x 0.6 (Figure 2a).
After explaining the risks and the benefits associated 
with VS treatment, the patient chose a conservative appro-
ach, with follow up by audiograms and MRI in series.
After 1 year of follow up, the patient reported a 
worsening in his tinnitus. Control audiogram showed a 
worsening in his hearing in the frequencies of 4, 6 and 8 
kHz. Control MRI did not show changes in tumor size. 
With patient participation we decided to keep the 
conservative approach.
The patient has been stable for 4 years, with impro-
vement in his hearing thresholds in the frequencies of 2 
and 3 kHz (Figure 1b), and a most recent MRI showed an 
important spontaneous tumor reduction (Figure 2b).
Figure 1. 1a) audiogram at the time of diagnosis; 1b) after 4 years of 
follow up.
Figure 2. 2a) MRI with gadolinium at the time of diagnosis; 2b) 4 years 
later, notice tumor involution.
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Case 2
MNLC, 60 years, female, white.
She came to us complaining of tinnitus in her right 
ear for 1 ear, without hearing loss or vertigo. Her physical 
exam was normal. Her audiogram showed a sensorineural 
hearing loss (45 dB HL) in 6 and 8kHz on the right side 
(Figure 3a). MRI showed a tumoral mass of the following 
dimensions: 0.7 x 0.4 x 0.4 cm in her right acoustic meatus 
(Figure 4a).
Because of her age, a small tumor size and preser-
ved hearing, in a joint process we decided for the conser-
vative approach, that is to follow her up with audiometric 
and image exams in series. 
After 2 years, the patient had one episode of sud-
den hearing loss and remained with an SRT of 65 dB and 
sound discrimination in 20% (Figure 3b). She was treated 
with prednisone, in the dose of 1mg/kg of body weight, 
and in the second week of drug treatment her hearing 
returned to the previous levels (3-c). Control MRI showed 
a reduction in VS size, shrinking down to 0.6 x 0.4 x 0.4 
cm (Figure 4b).
After a new discussion regarding treatment possibi-
lities, we decided to keep the conservative approach. 
Figure 3. 3a) audiogram at the time of diagnosis; 3b) after sudden 
death; 3c) after 2 years of follow up.
Figure 4. 4 a) MRI with gadolinium at the time of diagnosis; 4b) after 
two years.
DISCUSSION
The natural history behind VS is yet to be completely 
unveiled, however, it is known that most VS are of slow 
growth. Schuknecht, histologically reviewing 1400 tempo-
ral bones, found an incidence of 0.57% of VS. This is an 
extremely high value when we compare to the clinically 
diagnosed cases of VS which is of only 0.001%3. This di-
fference in numbers can indicate that most VS will never 
become clinically symptomatic, that is, most people with 
VS will have no consequences from the tumor ever4.
Even among diagnosed tumors, most of them (69%) 
do not grow after diagnosis and tumor involution is known 
to happen and has been described before6 with figures 
that reach 16% of the cases that had tumor shrinkage6. 
We unmistakably observed this phenomenon of tumor 
regression in the cases we report, for objecting to surgery 
these patients preferred the expectant approach. 
Of the small number of patients (31%) that show 
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some degree of tumor growth, it happens very slowly, 
70% have a growth at rates of less than 2mm per year6. 
Many authors confirm the slow growth of VS, presenting 
rates of 2.1mm per year or less2,6,7,9,10.
Unfortunately we can not state that all VS will grow 
slowly, because there is a relevant variation in tumor gro-
wth rate when we compare individuals with it. Thus, to 
follow the growth rate of VS in cases of small tumors during 
the fist year after diagnosis with image exams in series, 
allows us to predict tumor development in a patient during 
a period that varies between one and three years2,6,7.
Treatment of choice for VS still is complete tumor 
removal. The surgical microscope and modern surgical 
approaches for the pontine-cerebellar angle have brought 
about an important reduction in the surgery mortality rate, 
to less than 1%2, and today the goal is not only complete 
tumor removal, but also the preservation of facial and 
cochlear nerve function. Despite the high rates of treat-
ment success, there still is the possibility of facial paresis 
or paralysis or a worsening in postoperative auditory 
thresholds; and these are the factors that really impact the 
patient’s decision for a conservative approach. Our patient 
reported in case 1 had a mild worsening in his auditory 
threshold during this short observation period, only in 
the high frequencies, thus, the observing approach did 
not bring him any neurologic risk and he has been able 
to have what we call a “social hearing” throughout these 
last five years, which is something not guaranteed by 
surgery. At any time, if his hearing starts to go down, we 
can propose to discontinue this observational approach 
without harm to the patient. Another aspect that must be 
taken into account in dealing with intracanal VS cases is the 
improvement in hearing thresholds with the use of steroids 
after sudden hearing loss installs, and this was clearly seen 
in the patient presented in case 2. This patient received 
high doses (1mg/kg/day) and normalized her thresholds 
and sound discrimination in two weeks. The mechanism 
by which steroids would work in theses cases of sudden 
hearing loss in VS patients is still unknown, however the 
phenomenon has been described before.10
Considering the major progress of image exams 
lately, especially that of MRI, there are a larger number of 
patients with VS diagnosed earlier on. This means that we 
are diagnosing more and smaller tumors that cause less 
symptoms. Considering the natural history of VS, we still 
have the initial doubt about which treatment modality to 
choose from: the more aggressive surgical approach or the 
conservative, waiting and observing approach. Having in 
mind that, besides the slow growth rate associated with the 
tumor in most cases, we must also consider the possibilities 
of sequelae remaining from the surgical approach, which 
can be worse than the initial symptoms. 
The conservative approach is preferred by many au-
thors in a selected group of patients: those with advanced 
age, minimum symptoms, unfavorable clinical conditions, 
small tumors, tumors in a single ear or those who do not 
wish to operate, as long as this does not bring about any 
neurologic risk. 
We must consider that the conservative approach 
does not mean surgery aversion, but rather an initial follow 
up in order to see if the tumor the patient harbors is of slow 
or fast growth. The surgical approach can be considered 
when there is a fast increase in tumor size seen in a series 
of image exams, when there is symptoms worsening or 
even in those patients who first decided for a conservative 
approach but later decide for a more definitive treatment. 
We must also stress that audiogram worsening is not sta-
tistically associated with tumor growth11.
According to Fisch5, the initial conservative appro-
ach is worth it because only 12% of the patients included 
in his research who were initially included in the group 
for conservative treatment ended up requiring surgery. In 
these patients, tumor growth rate was much greater when 
compared to those who did not require surgery, and mo-
reover the initial tumor size was statistically larger. 
The second issue at hand when we decide for a 
conservative approach in cases of VS is whether we are 
truly bringing any benefit to the patient when we wait on 
surgery. Tumor observation time should not allow for a 
worsening in clinical status, thus compromising surgical 
prognosis. Some studies have compared patients who 
were submitted to surgery immediately after diagnosis 
with those who decided for the conservative approach and 
were later operated, and these did not show statistically 
significant differences as far as postoperative sequelae 
are concerned; thus ratifying the conservative approach 
in cases of VS6,7,9.
FINAL REMARKS
A conservative approach should be always consi-
dered in patients diagnosed with VS, especially in patients 
with minimum symptoms, advanced age, patients with 
other clinical issues, small tumors, tumors in one ear only 
or those patients who do not wish to undergo surgery. We 
have to base ourselves on the fact that tumor growth rates 
in the first year after diagnoses predicts tumor behavior in 
the following years. The conservative approach can not be 
inflexible, and should be abandoned in light of evidence 
of fast tumoral growth, worsening in symptoms or even 
patient wish. A small number of patients who were initially 
submitted to conservative treatment needed surgery later 
on. And finally, a conservative approach to VS does not 
bring greater risks to the patient, since it does not worsen 
a later surgical prognosis. 
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